ReviewHuman vaccines & immunotherapeutics2025
Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico.
Daisuke Kuroda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it